Chunk #35 — RESULTS — Medication by OPRM1 and DAT genotypes — Bar Lab Drinking

Source

Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.

Embedded

yes

Text

There were no significant main effects of DAT genotype (F(1,81)=2.14, p =0.15) or interactions with OPRM1 (F(3,79)=0.77, p=0.52) or medication (F(1,79)=0.01, p=0.92) on alcohol consumed after the priming drink in the bar lab.